Helen C. Adams - Jun 20, 2025 Form 4 Insider Report for Immix Biopharma, Inc. (IMMX)

Role
Director
Signature
/s/ Ilya Rachman as Attorney-In-Fact for Helen C. Adams
Stock symbol
IMMX
Transactions as of
Jun 20, 2025
Transactions value $
$0
Form type
4
Date filed
6/23/2025, 04:57 PM
Previous filing
Jun 21, 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Adams Helen C. Director 11400 WEST OLYMPIC BLVD.,, SUITE 200, LOS ANGELES /s/ Ilya Rachman as Attorney-In-Fact for Helen C. Adams 2025-06-23 0001488486

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding IMMX Common Stock 175K Jun 20, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMMX Stock Option (Right to Buy) Award $0 +33K $0.00 33K Jun 20, 2025 Common Stock 33K $2.24 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Stock Option will vest in twelve (12) equal monthly installments following the date of grant, subject to the Reporting Person's continued service on the Board of Directors.

Remarks:

See Power of Attorney filed as Exhibit 24.1 to the Form 3 filed by the Reporting Person on December 15, 2021.